Discusses the advances in the understanding of hypercoagulability in venous and arterial thrombosis. Use of fibrinogen levels when assessing patients at risk for acute myocardial infarction; Importance of a genetic component in the pathogenesis of venous thrombosis; Influence of hypercoagulability on the pathogenesis of coronary heart disease.